TCG Labs-Soleil is a venture capital firm based in South San Francisco that was founded in 2023. It is a partnership between TCG Labs Fund I and Soleil, an independent R&D hub. TCG Labs-Soleil's model is a "venture capital-biotech" model that combines TCG Labs Fund I and Soleil to establish and oversee a suite of portfolio programs. TCG Labs-Soleil's integrated ecosystem helps to fund, discover, and develop single-asset biologic therapies. 

TCG Labs - Soleil

Director / Senior Director, CMC Process Development & Manufacturing

Senior Scientist, Antibody Engineering

Senior Research Associate, Molecular Biology and Expression

At TCG Labs-Soleil, we're all about bringing together smart people and their brilliant ideas to make a real difference in healthcare. We form and manage independent portfolio companies, each with their own special project, guiding them from the drawing board to the real world where they can start changing lives.

We're not just about one thing; whether it's biologics, small molecules, or anything in between, we want to hear about it. Our goal? To make sure no good idea goes unnoticed. We love new ideas, whether they come from a university lab, a biotech startup, or a chat over coffee with industry friends. 

Let's make something amazing together!  https://lnkd.in/gCV9YAp5

#InnovationForHealth #BigIdeas #HealthcareHeroes #MakingADifference #JoinUs

Hey there, scientific innovators! If you’ve been dreaming up ways to tackle serious health issues and have a novel idea, we're looking for you. With a track record of transforming big ideas into real treatments, we've got the brains and the heart to bring your vision to life.

Picture this: the energy and excitement of a startup, combined with the wisdom of experts who've been there, done that, and the kind of funding that says, "Yes, we believe in this." Sounds good? Let's make it happen.

Ready to learn more? Click here: https://lnkd.in/gCV9YAp5

#DreamTeam #HealthInnovation #StartupVibes #ChangeMakers

TCG Labs Soleil is building a suite of home-grown portfolio companies, each individually focusing on single-asset programs spanning #autoimmune diseases to #oncology.  

Curious? 

Let’s connect. 

#biotech #pharma #partnering 

Early 2024 saw an uptick in dealmaking activity in the bio/pharma industry, and this momentum is likely to continue. What is attractive? Acquiring de-risked, quality assets that can uplift the innovation deficit and replenish revenue streams. TCG Labs Soleil is poised to deliver. Our model offers pharma and biotech with vetted assets ready for efficient adoption and development.  Learn more: https://lnkd.in/gCV9YAp5

Our unique "One Lab, One Team" model breaks down traditional barriers, allowing us to act swiftly, kickstart projects with high potential, and navigate past the common obstacles that hinder the development of groundbreaking drugs. Here, every member is empowered and incentivized like a scientific founder, driving them to approach each therapeutic program with the dedication and urgency of a "lead asset."  

How a VC and a biotech founder plan to create a new biotech model - San Francisco Business Times - The Business Journals

Couldn't make it to this year's #BIO International Convention? That's okay! We're always excited to hear from #scientific founders, innovators, and potential #partners. Reach out to Lucinda Quan and Eric Gomez anytime—and follow us to see how our portfolio companies and programs grow from innovative ideas to experimental validation. We look forward to exploring opportunities together.

Exclusive: Column Group raises a new $400M+ fund and R&D hub for single-asset biologics companies - Endpoints News

At TCG Labs-Soleil, we're pioneering a new era of drug discovery, offering unique advantages to scientific founders, drug hunters, and the pharma and biotech industries. Our model is designed to streamline the journey from idea to clinical application. This includes:

🚀 Efficient R&D: Scientific founders gain access to a top-tier drug discovery team and dedicated funding, ensuring a smooth transition from concept to reality.

🎯 Focused Approach: We form portfolio companies around single-asset programs, emphasizing efficient development and clinical validation.  

🤝Simple Transactions: Our model supports flexible, strategic partnerships, each grounded in human proof of concept and ready for seamless integration into late-stage development efforts.

🔬 One Lab, One Team: Our evergreen team model ensures continuity, focus, and productivity, allowing us to excel in what we do best – innovating for the future of healthcare.

Discover how TCG Labs-Soleil can revolutionize your drug development pipeline. Learn more: https://lnkd.in/gzspeSsd 

#PharmaPartnerships #Founders #BiotechInnovation #TCGLabsSoleil #DrugDiscovery

Meet Dr. Josh Lichtman, Chief Science Officer and Co-Founder of TCG Labs Soleil. Josh leads our top-notch R&D hub, guiding a stellar scientific team dedicated to efficient drug development that result in innovative single-asset programs. Learn more about Josh: https://lnkd.in/gXN2vEJb
#MeetOurTeam #InnovationInScience  

Meet Jin-Long Chen , CEO of TCG Labs-Soleil.  A drug discovery expert at his core, he has successfully guided programs from the earliest stages to developing multiple new medicines that have positively impacted #patient care. Read more: https://lnkd.in/gBm_Ej49

Are you headed to San Diego? TCG Labs-Soleil will be at BIO International Convention 2024 June 3-6. Let's connect and explore opportunities together. Schedule a BIO One-on-One Partnering meeting with us. Looking forward to great conversations! Learn more: https://lnkd.in/gi5_GMyh

TCG Labs - Soleil

About: